Tight blood pressure control decreases apoptosis during renal damage.
D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects*; D001794:Blood Pressure / Q000187:drug effects*; D002455:Cell Division / Q000187:drug effects; D004359:Drug Therapy, Combination; D006830:Hydralazine / Q000494:pharmacology; D006852:Hydrochlorothiazide / Q000494:pharmacology; D006977:Hypertension, Renal / Q000188:drug therapy* / Q000473:pathology*; D007150:Immunohistochemistry; D019808:Losartan / Q000494:pharmacology; D008297:Male; D011507:Proteinuria / Q000188:drug therapy / Q000473:pathology; D000077583:Quinapril; D051381:Rats; D011918:Rats, Inbred SHR; D011921:Rats, Inbred WKY; D012110:Reserpine / Q000494:pharmacology; D044005:Tetrahydroisoquinolines / Q000494:pharmacology*
D000959:Antihypertensive Agents; D044005:Tetrahydroisoquinolines; D006852:Hydrochlorothiazide; D006830:Hydralazine; D012110:Reserpine; D019808:Losartan; D000077583:Quinapril